Physician

Jeffrey Barton Gelblum, MD

According to 2025 Medicare claims, Jeffrey Gelblum, MD (NPI: 1124057898) practices neurology in the West Palm Beach-Boca Raton-Delray Beach, FL market, with the plurality of this provider's patient population coming from Palm Beach, FL. This provider's primary affiliated billing organization is NEUROSCIENCE CONSULTANTS LLP (NPI: 1346217452; TIN: 542107535) and primary practice location at 33458-2788.

Gelblum's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 756 traditional Medicare patients, billed 88,929 HCPCS/CPT codes, and received $1,591,480 in Medicare payments. The top billing code was 95819 (Measurement of brain wave activity (eeg), awake and asleep). Part D data shows 1,269 prescription claims across 313 beneficiaries totaling $1,540,568 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). Open Payments data shows 235 records totaling $94,879. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $111,369 to $1,591,480. Similarly, Part D prescription costs have moved sharply higher in recent years, from $308,920 to $1,540,568. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	157	931	$111,369
2016	161	964	$112,661
2017	185	1,117	$122,816
2018	226	2,615	$187,704
2019	276	7,617	$465,076
2020	253	14,378	$435,609
2021	283	10,923	$347,150
2022	337	14,279	$457,831
2023	379	21,605	$1,085,924
2024	756	88,929	$1,591,480

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	141	1,121	$308,920
2016	167	1,190	$302,479
2017	173	886	$215,707
2018	228	1,019	$367,329
2019	251	1,160	$800,286
2020	266	1,372	$915,892
2021	272	1,481	$1,173,201
2022	274	1,383	$1,428,567
2023	294	1,493	$1,250,530
2024	313	1,269	$1,540,568

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95819	Measurement of brain wave activity (eeg), awake and asleep	215	216	$364
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	335	574	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	418	844	$83
92653	Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report	218	219	$68
95930	Measurement of nerve conduction using visual stimulation testing with report	217	218	$54

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	12	336	$327,115
Gammaked	Immune Globul G/Gly/Iga Avg 46	20	560	$315,747
Gamunex-C	Immune Globul G/Gly/Iga Avg 46	11	330	$124,532
Rexulti	Brexpiprazole	20	600	$28,896
Aimovig Autoinjector	Erenumab-Aooe	18	720	$17,805

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	234	$94,149	Eisai Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$730	Eli Lilly and Company
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jeffrey Barton Gelblum, MD?

Tedicare shows public-source Medicare data for Jeffrey Barton Gelblum, MD (NPI 1124057898), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Barton Gelblum, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Barton Gelblum, MD?

Jeffrey Barton Gelblum, MD is linked to NEUROSCIENCE CONSULTANTS LLP (billing NPI 1346217452) in the available physician profile data.

Does Jeffrey Barton Gelblum, MD have Open Payments data?

Jeffrey Barton Gelblum, MD has 235 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.